Company intelligence / Profile preview
ARJIL Pharmaceuticals
Taiwan Province of Chinaarjilpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
ARJIL Pharmaceuticals is a clinical-stage biopharmaceutical company founded in Taiwan in 2014. It develops innovative botanical-based medicines and small molecules targeting age-related conditions and immune/inflammatory disorders. Its lead program AR‑100 has reached Phase I/II trials for atopic dermatitis; other pipeline assets remain preclinical or earlier.[6][3] The company has raised over $8 million USD in funding as of early 2024.[6] No commercialized products yet.
- Therapeutic areas
- GastroenterologyCardiovascularRheumatologyImmunologyDermatologyNeurologyInfectious Diseases
- Modalities
- Botanical-based medicines (herbal medicines)Small molecule drugsBiological productsAptamers[6][1][3]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
No major pharmaceutical partnerships disclosed publicly. Some licensing from Industrial Technology Research Institute noted for lead asset originator.[3]
Beyond the preview
Go deeper on ARJIL Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ARJIL Pharmaceuticals.